Related references
Note: Only part of the references are listed.MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate
Sara Abdelfatah et al.
ACTA PHARMACEUTICA SINICA B (2019)
Design, synthesis and evaluation of D-amino acid-containing peptidomimetics targeting the polo-box domain of polo-like kinase 1
Zhiyan Li et al.
BIOORGANIC CHEMISTRY (2019)
Ligand-based computer aided drug design reveals new tropomycin receptor kinase a (TrkA) inhibitors
Rand Shahin et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Halogen bonding in the framework of classical force fields: The case of chlorine
Davide Franchini et al.
CHEMICAL PHYSICS LETTERS (2018)
Deep reinforcement learning for de novo drug design
Mariya Popova et al.
SCIENCE ADVANCES (2018)
Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors
Lubna Swellmeen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
A New Class of Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1
Mija Ahn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors
Sawsan Abuhamdah et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads
Rand Shahin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro- pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors
Michele Caruso et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Design of Potent and Selective Hybrid Inhibitors of the Mitotic Kinase Nek2: Structure-Activity Relationship, Structural Biology, and Cellular Activity
Paolo Innocenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor
Italo Beria et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties
Tara R. Rheault et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors
Italo Beria et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration
Reema Abu Khalaf et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification of 2-Anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as Dual PLK1/VEGF-R2 Kinase Inhibitor Chemotypes by Structure-Based Lead Generation
Anne-Marie Egert-Schmidt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors
Italo Beria et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Best Practices for QSAR Model Development, Validation, and Exploitation
Alexander Tropsha
MOLECULAR INFORMATICS (2010)
Discovery of thiophene inhibitors of polo-like kinase
Kyle A. Emmitte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
Kyle A. Emmitte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors
Areej M. Abu Hammad et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors
Emily J. Hanan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors
Raymond V. Fucini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1
M. Cheung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Discovery of DPP IV Inhibitors by Pharmacophore Modeling and QSAR Analysis followed by in silico Screening
Ihab M. Al-masri et al.
CHEMMEDCHEM (2008)
Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - What can we learn from earlier mistakes?
Johannes Kirchmair et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2008)
On some aspects of validation of predictive quantitative structure-activity relationship models
Kunal Roy
EXPERT OPINION ON DRUG DISCOVERY (2007)
Structure of the catalytic domain of human polo-like kinase 1
Michael Kothe et al.
BIOCHEMISTRY (2007)
Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors
I Akritopoulou-Zanze et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
An introduction to ROC analysis
Tom Fawcett
PATTERN RECOGNITION LETTERS (2006)
Ligand-based assessment of factor Xa binding site flexibility via elaborate pharmacophore exploration and genetic algorithm-based QSAR modeling
MO Taha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Pharmacophore modeling and three dimensional database searching for drug design using catalyst:: Recent advances
O Güner et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Virtual screening using protein-ligand docking: Avoiding artificial enrichment
ML Verdonk et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Improving structure-based virtual screening by multivariate analysis of scoring data
M Jacobsson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models
A Tropsha et al.
QSAR & COMBINATORIAL SCIENCE (2003)
LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites
CM Venkatachalam et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Beware of q(2)!
A Golbraikh et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2002)
Share Paper
